An underlying goal of synthetic biology is to make the process of engineering biological systems easier and more reliable. In support of this goal, we developed BioBrick assembly standard 10 to enable the construction of systems from standardized genetic parts. The BioBrick standard underpins the distributed efforts by the synthetic biology research community to develop a collection of more than 6000 standard genetic parts available from the Registry of Standard Biological Parts. Here, we describe the three antibiotic assembly (3A assembly) method for physical composition of BioBrick parts and provide step-by-step protocols. The method relies on a combination of positive and negative selection to eliminate time-and labor-intensive steps such as column cleanup and agarose gel purification of DNA during part assembly.
Introduction
A fundamental goal of synthetic biology is to make the process of designing, building and testing biological systems easier and more reliable. Drawing inspiration from other engineering fields, we have been working to develop methods that support the design and construction of multi-component, synthetic biological systems from standardized biological parts. In 2002, Knight proposed and implemented the BioBrick standard for assembly of standard genetic parts (Knight, 2003) . Parts that have been refined to adhere to the BioBrick assembly standard are called BioBrick standard biological parts. The key innovation of the BioBrick standard is that assembly of any two BioBrick parts yields a composite object that is itself a BioBrick part that can be further combined with any other BioBrick parts. The idempotent nature of the BioBrick standard has helped to support the distributed development of a collection of over 6000 standard biological parts in the Registry of Standard Biological Parts (http://partsregistry.org). Parts in the Registry are catalogued, describing and conveying units of biological function rather than simply arbitrary DNA sequences. Participants in the international Genetically Engineered Machines competition (iGEM, http://igem.org) as well as many academic laboratories have made use of the BioBrick assembly standard in construction of genetic parts, devices and systems (Levskaya et al., 2005; Ajo-Franklin et al., 2007; Canton et al., 2008; Haynes et al., 2008; Shetty et al., 2008; Du et al., 2009; Kelly et al., 2009; Tabor et al., 2009; Agapakis et al., 2010; Afonso et al., 2010; Grünberg et al., 2010; Huang et al., 2010) . Several additional physical composition standards have been proposed that extend or build upon the BioBrick assembly standard (Phillips and Silver, 2006; Knight, 2008; Ellison et al., 2009; Grünberg et al., 2009; Peisajovich et al., 2009; Anderson et al., 2010) . The BioBricks Foundation (BBF) now manages an open standards setting process for the synthetic biology community via the submission and publication of requests for comment (RFCs). In accordance with BBF RFC 29, the BioBrick assembly standard is now referred to as BioBrick assembly standard 10 in the Registry of Standard Biological Parts and other assembly standards are similarly numbered (Shetty and Rettberg, 2009 ).
For brevity, here we use the term BioBrick parts to refer to parts that adhere to BioBrick assembly standard 10.
In addition to supporting the distributed development of a collection of standard biological parts, the BioBrick standard also enables the iterative and pairwise hierarchical assembly of genetic parts into systems containing many parts. The standard prescribes specific sequences, termed the prefix and suffix sequences, that must flank the 5' and 3' ends of a genetic part, respectively ( Figure 1A and 1B). The prefix sequence encodes an EcoRI and XbaI restriction enzyme recognition site and the suffix sequence encodes a SpeI and PstI recognition site. In addition, the standard prescribes that the sequence of the genetic part itself must not contain recognition sites for EcoRI, XbaI, SpeI or PstI enzymes. During assembly of any two BioBrick parts, the 3' end of the upstream part is digested with SpeI and the 5' end of the downstream part is digested with XbaI. Since SpeI and XbaI produce compatible cohesive ends, ligation of the upstream and downstream parts produces an 8 bp "mixed" or "scar" sequence between the two parts that is not recognized by either enzyme ( Figure 1C ). Since the resulting composite part is still flanked by the prefix and suffix sequences, it can again be digested with either XbaI or SpeI during a subsequent assembly step. Hence, a biological engineer can use the same, iterative process of restriction digestion and ligation to assemble multiple parts into a synthetic biological system. Although the BioBrick standard constrains the sequence of the genetic parts as well as the overall assembly approach, it does not specify the methods used during the assembly process. As a result, there has been some variation and experimentation on assembly methods by different research groups (Knight, 2003; Sleight et al., 2010) . Here, we describe a method for assembly of BioBrick parts called three antibiotic assembly (3A assembly, Figure 2 ). We designed the 3A assembly method to make use of negative and positive selection to reduce the number of possible incorrect assembly products. The inputs to the process are plasmids propagating an upstream part, a downstream part, and a destination vector into which the two parts will be assembled. The destination vector must have a different antibiotic resistance marker from the plasmids encoding the upstream and downstream parts. (The name 3A assembly derives from the maximum of three antibiotic resistance markers needed for any assembly step.) The upstream part is digested with EcoRI and SpeI, the downstream part is digested with XbaI and PstI and the destination vector is digested with EcoRI and PstI. The three digested plasmids are then mixed, ligated and transformed with no intervening purification steps. Given the variety of DNA fragments present in the ligation reaction, an assortment of ligation products are possible in 3A assembly (Figure 3) . Fortunately, transformation and subsequent colony growth on selective media constitute strong selective pressure for circular ligation products that include the destination vector. In addition, propagation of the uncut or recircularized destination plasmid is selected against by inclusion of the ccdB positive selection marker in the BioBrick cloning site of the destination vector (Bernard et al., 1994; Bernard, 1995; Bernard, 1996) . Ligation products composed of part concatemers, though possible, occur with significantly lower probability than the desired ligation product. Finally, ligation products with two or more identical replication origins usually fail to propagate in growing E. coli cells. Hence, there is significant positive and negative selective pressure for the transformation and propagation of the desired assembly product. As an additional benefit of the 3A assembly method, it is very amenable to scale up and automation because it avoids difficult-to-automate steps such as column cleanup and agarose gel purification of DNA. We have successfully used the method to assemble parts ranging in length from 12 bp to 3-4 kb. Below, we provide detailed protocols for the construction and 3A assembly of BioBrick parts. All protocols are adapted from standard molecular biology techniques and/or the manufacturer's directions, unless otherwise specified (Sambrook and Russell, 2001 ).
Construction of new BioBrick standard biological parts
To adhere to BioBrick assembly standard 10, genetic parts must be designed with specific prefix and suffix sequences ( Figure 1A ). The suffix sequence for all BioBrick genetic parts is 5' TACTAGTAGCGGCCGCTGCAG 3'. The prefix sequence for genetic parts, with the exception of protein coding sequence parts, is 5' GAATTCGCGGCCGCTTCTAGAG 3'.
For protein coding sequences beginning with an ATG start codon, the prefix sequence is truncated by 2 nt at the 3' end ( Figure 1B) . The 2 nt truncation ensures that, when assembled together, two genetic parts encoding a ribosome binding site and a protein coding sequence have a suitable spacing between the Shine-Dalgarno sequence and the ATG start codon to promote efficient translation in E. coli and related organisms (Chen et al., 1994) . Hence, the prefix sequence for protein coding sequence parts beginning with an ATG start codon is 5' GAATTCGCGGCCGCTTCTAG 3'. An additional constraint on the sequence of parts conforming to BioBrick assembly standard 10 is that recognition sites for the following restriction enzymes must be absent: EcoRI, XbaI, SpeI, and PstI.
New BioBrick parts can be constructed by either PCR amplification from template DNA or by de novo DNA synthesis. For PCR-based construction of parts, we routinely use the primer sequences listed in Table I in which the prefix and suffix sequences are encoded on the forward and reverse primers, respectively. Both the forward and reverse amplification primers are designed to have an extra 8 nt of sequence on the 5' end. The 8 nt spacer sequence serves two purposes. First, it enables efficient cleavage of the linear PCR product by EcoRI or PstI, as restriction enzymes cleave less efficiently near DNA termini (Moreira and Noren, 1995) . Second, the selected sequence GTTTCTT was found to promote the addition of a 3' A overhang by Taq polymerase thereby facilitating downstream TA cloning of the PCR amplified part (Brownstein et al., 1996) . Optimal PCR conditions will vary based on part length, sequence, and amplification primers.
When constructing a new part by PCR amplification, any EcoRI, XbaI, SpeI or PstI recognition sites present in the part sequence must be eliminated by site-directed mutagenesis. For parts that are constructed by de novo DNA synthesis, we recommend eliminating the restriction sites listed in Table II when possible to facilitate conversion to other BioBrick assembly standards, part reuse and downstream cloning operations. We also recommend cloning constructed parts into a standard BioBrick vector prior to 3A assembly.
3A assembly of BioBrick standard biological parts
To assemble two BioBrick parts together into a destination vector via 3A assembly 6. Prepare a transformation reaction by adding 1 µL of ligation reaction to 15-50 µL competent cells in a pre-chilled 2 mL eppendorf tube. Increasing the amount of ligation product in the transformation reaction is usually not effective in increasing the number of transformants. Less than 5% of the transformation reaction volume should consist of ligation product. A 2 ml rather than a 1.7 ml eppendorf tube provides better mixing and aeration of the cell culture during outgrowth in a rotator (Step 11).
7. Incubate the transformation reaction on ice for 30 minutes.
8. Immerse the transformation reaction in a 42°C water bath for 60 seconds to heat shock the cells.
9. Incubate the transformation reaction on ice for 2 minutes.
10. Add 200 µL sterile SOC media to the transformation reaction to begin cell outgrowth.
11. Incubate the transformation reaction at 37°C for 2 hours with gentle shaking.
Although a 1 hour incubation is sufficient for destination vectors with ampicillin or kanamycin resistance markers, we have found that a 2 hour incubation results in an increased number of colonies for destination vectors with chloramphenicol or tetracycline markers.
12. Using sterile 3 mm glass beads, spread 200 µL of the transformation reaction on an LB agar plate supplemented with the antibiotic corresponding to the destination vector. Sterile glass beads are preferable to a glass spreader because multiple transformation reactions can be plated simultaneously.
13. Incubate transformation plates overnight at 37°C for colony growth. 
Verification of correct assembly of BioBrick standard biological parts
Based on our empirical observations, 3A assembly usually yields more than 80% correct clones, assuming that the assembled parts confer no significant growth disadvantage to the host strain. To confirm that two parts have been correctly assembled together via 3A
assembly, we routinely screen colonies for sensitivity to the antibiotic(s) corresponding to the two part vectors and verify the length of the assembled part by colony PCR followed by agarose gel elecrophoresis as described below (Güssow and Clackson, 1989) . Clones that pass these two checks are then analyzed by DNA sequencing.
1. Use a sterile tip to pick, inoculate and mix a colony into 20 µL of sterile H 2 O.
We generally pick 4 or 8 colonies from each transformation plate. For this and all subsequent steps, we use 8-strip PCR tubes and/or 96-well plates to facilitate use of a multi-channel pipettor for the transfer operations.
2. Transfer ~2 µL of the colony suspension onto four LB-agar plates each supplemented with one of ampicillin, kanamycin, chloramphenicol and tetracycline. Incubate the plates either at room temperature overnight or at 37°C
for 6-8 hours to check for the expected antibiotic resistance and sensitivity.
3. For each colony suspension, prepare 9.5 µL PCR mix using primers BioBricks-f
and BioBricks-r that anneal to the BioBrick prefix and suffix, respectively (Table   I ). Transfer 0.5 µL colony suspension to each reaction tube and run PCR in a programmable thermocycler. Optimal PCR conditions will vary based on part length and sequence but generally an annealing temperature of 56-58°C works well with these primers. We prefer to use colony verification primers BioBricks-f
and BioBricks-r rather than sequencing primers VF2 and VR in this step to test for the presence of a BioBrick prefix and suffix in the assembled clones.
4. Analyze the resulting reactions by agarose gel electrophoresis. Confirm that the PCR product has the expected length by comparison to a molecular weight standard (DNA ladder).
5. Sequence plasmid DNA from 1-2 colonies per assembly from those colonies that pass both the antibiotic resistance/sensitivity test and length verification test. We routinely use primers VF2 and VR for sequence verification of parts assembled in BioBrick vectors (Table I) .
Preparation of linearized destination vector by PCR to improve 3A assembly
Our driving goal in designing the 3A assembly process was to limit the number of possible incorrect assembly products as much as possible by leveraging a combination of positive and negative selection (Figure 3) . Hence, incorrect clones arising from 3A assembly are of significant interest because they inform further improvements to the process. In our experience, the three most common failure modes of 3A assembly are the following. First, colonies on the transformation plate are resistant to the antibiotic corresponding to not only the destination vector but also one of the parent vectors. Such a result generally arises from a co-transformation, or possibly a ligation followed by transformation, of the part and destination vectors. Second, a contaminating E. coli genomic DNA fragment ligates to the destination vector backbone and is transformed. In this error case, the genomic DNA fragment is often flanked by EcoRI and PstI sites and can ligate directly to the destination vector. Such a two-fragment ligation event competes with the desired three-fragment ligation event needed for correct part assembly. Third, uncut or recircularized destination vector propagates in the host strain as a result of a loss-of-function mutation in the ccdB positive selection marker.
While the verification tests described above can generally detect these three error cases prior to DNA sequencing, we prefer to reduce or eliminate these failure cases if possible.
In particular, both the second and third failure modes described above stem from issues arising during preparation and digestion of the destination vector. To further reduce the number of possible incorrect assembly products in 3A assembly, we recommend preparing the destination vector by PCR instead of by plasmid DNA purification. Such an approach nearly eliminates contaminating genomic DNA in the destination vector digestion reaction, thereby reducing competition from EcoRI/PstI linearized genomic DNA fragments in the ligation reaction (second failure mode). Similarly, preparation of the destination vector by PCR also reduces contaminating uncut destination plasmid from the transformation reaction (third failure mode). Since destination vectors can be prepared in batches in advance of any assembly steps, the duration and automation of the 3A assembly process is unaffected by these improvements.
1. Amplify the pSB1A3, pSB1K3, pSB1C3 and pSB1T3 destination vectors by PCR using primers SB-prep-3P and SB-prep-2Eb (Table I) . Prepare each amplification reaction with 1X PCR SuperMix High Fidelity (Life Technologies, Carlsbad, CA), 60 pmol each primer and 2-5 ng template destination plasmid in a 100 µL total volume. We designed the primers to amplify the destination vector with only EcoRI and PstI recognition sites, leaving only the minimal number of bases 5' to the sites to allow efficient DNA cleavage of the vector by these enzymes.
The resulting short fragments produced from digestion of the PCR-amplified destination vector are too short for ligation during assembly, increasing the efficiency of the assembly step by limiting competing ligation products.
2. Thermocycle the reactions using the following conditions.
1. Initial denaturation at 94°C for 1 minute.
2. Denaturation step at 94°C for 30 seconds.
3. Annealing step at 58°C for 30 seconds.
4. Extension step at 68°C for 3 minutes.
5. Cycle 40 times to step 2.
6. Final extension at 68°C for 10 minutes.
3. Add 1 ul DpnI to each reaction.
4. Incubate all reactions at 37°C for 1 hour to digest the template DNA and then at 80°C for 20 minutes to heat inactivate the restriction enzyme. For convenience, we recommend performing this step in a programmable thermocycler.
5. Confirm by agarose gel electrophoresis that the full-length destination vector is primary PCR product.
6. Purify the PCR product using the QIAquick PCR Purification Kit from QIAGEN or similar kit to remove enzymes and dNTPs.
7. The resulting PCR-amplified destination vector can be used directly in the EcoRI and PstI digestion of a 3A assembly step. We do not recommend storage of digested linearized plasmid backbones.
Available BioBrick destination vectors
Several standard BioBrick assembly vectors are available from the Registry of Standard Biological parts including high copy vectors pSB1A3, pSB1K3, pSB1C3, pSB1T3, pSB1AK3, pSB1AC3 and pSB1AT3. In addition, a selection of low and medium copy BioBrick vectors are also available from the Registry including pSB4A5, pSB4K5, pSB4C5, pSB4T5, pSB3K5, pSB3C5 and pSB3T5 (Shetty et al., 2008) . All of these vectors contain a BioBrick cloning site and primer binding sites for verification primers VF2 and VR. The VF2 and VR primer binding sites are positioned at a sufficient distance from the cloning site to allow high quality sequence reads of BioBrick parts from Sanger sequencing. Use of part plasmids and destination plasmids with different replication origins can increase the likelihood that ligation products containing two replication origins will propagate during cell growth (first failure mode described above).
Preparation of chemically competent cells
A key factor in the success of 3A assembly of BioBrick parts is the transformation efficiency of the competent cells used. Low efficiency competent cells can result in few or no colonies on the transformation plate. We have tested several different protocols for preparation of chemically competent cells and have found that the following protocol yields competent cells with high transformation efficiency. It builds on extensive prior work on bacterial transformation (Hanahan et al., 1991) . We have used this protocol successfully with E. coli strains TOP10 and Mach1.
1. Detergent residue inhibits competent cell growth and transformation. Remove detergents from all glassware by autoclaving glassware filled ! full with DI water prior to use. Prepare all media and buffers in detergent-free glassware. Similarly, grow cultures in detergent-free glassware.
2. Prepare CCMB80 buffer.
• 10 mM KOAc pH 7.0 (10 mL of a 1M stock solution)
• 20 mM MnCl 2 !4H 2 O (4.0 g/L)
• 10 mM MgCl 2 !6H 2 O (2.0 g/L)
• 10% glycerol
• Adjust pH down to 6.4 with 0.1N HCl if necessary.
• Filter sterilize and store at 4°C.
3. Streak the E. coli strain on an SOB agar plate and grow at 23°C until single colonies appear.
4. Prepare a set of seed cultures by picking single colonies into several culture tubes each with 2 mL SOB medium. Shake culture tubes at 23°C overnight.
5. Prepare frozen seed stocks by adding sterile glycerol to a final concentration of 15% to each seed culture. Aliquot 1 mL seed culture into cryogenic vials. Freeze seed stocks in a dry ice/ethanol bath and store at -80°C.
6. Inoculate 250 mL SOB medium with a 1 mL vial of seed stock and grow at 20°C
to an OD600nm of 0.3. This culture may be grown at room temperature if necessary.
7. Chill glassware, plasticware and reagents prior to use.
8. Centrifuge the culture at 3000 x g at 4°C for 10 minutes in a flat bottom centrifuge tube. The cell pellet is easier to resuspend in a flat bottom tube.
9. Gently resuspend cell pellet in 80 mL of ice cold CCMB80 buffer. To make cell resuspension easier, initially add a small volume of buffer, resuspend and then add the rest of the buffer.
10. Incubate resuspended culture on ice for 20 minutes.
11. Centrifuge resuspended culture at 3000 x g at 4°C for 10 minutes and gently resuspend cell pellet in 10 mL ice cold CCMB80 buffer.
12. Measure the OD600nm of a mixture of 200 µL SOC and 50 µL resuspended culture. Add sufficient chilled CCMB80 buffer to resuspended culture to yield a final OD600nm of 1.0-1.5 in this measurement.
13. Incubate the resuspended culture on ice for 20 minutes.
14. Aliquot competent cells into pre-chilled tubes and store at -80°C.
15. Measure transformation efficiency of prepared competent cells using plasmid DNA. Target transformation efficiency is >10 8 cfu per µg of plasmid DNA.
Conclusions
3A assembly is a method for the assembly of standard biological parts that conform to BioBrick assembly standard 10. The 3A assembly method relies on a combination of positive and negative selection to achieve a high frequency of correctly assembled clones (>80% in our experience). It avoids labor-intensive, difficult-to-automate steps such as column cleanup and agarose gel purification and we have used it successfully with parts ranging in length from 12 bp to 3-4 kb. To use 3A assembly, the destination vector, into which two BioBrick parts will be assembled, must have a different antibiotic resistance marker from the plasmids encoding the two input parts. The 3A assembly method is extensible to other BioBrick assembly standards, assuming that the restriction enzymes used can be heat inactivated. 
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